Choline C-11 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
4635 94793-58-5

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • Choline C 11
  • Choline C 11 Injection
  • Choline C11
  • Choline C-11
  • Molecular weight: 103.17
  • Formula: C5H14NO
  • CLOGP: -4.36
  • LIPINSKI: 0
  • HAC: 2
  • HDO: 1
  • TPSA: 20.23
  • ALOGS: -1.59
  • ROTB: 2

  • Status: OFP

  • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
azlogd74 LogD at pH 7.4 -4.397 High 1
caco2-efflux Caco-2 efflux ratio (BA/AB) 0.042 High 1
caco2-intrinsic-papp Caco-2 intrinsic apparent permeability 0.493 10^-6 cm/s High 1
dh-clint Dog hepatocyte intrinsic clearance 3.483 uL/min/10^6 cells High 1
dppb Dog plasma protein binding (% unbound) 84.300 % High 1
fcs-ppb Fetal calf serum protein binding (% unbound) 33.640 % High 1
herg hERG pIC50 3.917 pIC50 High 1
hh-clint Human hepatocyte intrinsic clearance 1.524 uL/min/10^6 cells High 1
hlm-clint Human liver microsomal intrinsic clearance 2.477 uL/min/mg protein High 1
hppb Human plasma protein binding (% unbound) 84.510 % High 1
mdck-mdr1-efflux MDCK-MDR1 efflux ratio 0.041 High 1
mh-clint Mouse hepatocyte intrinsic clearance 2.704 High 1
mppb Mouse plasma protein binding (% unbound) 94.350 High 1
nih-mdck-mdr1-efflux NIH MDCK-MDR1 efflux ratio 0.128 High 1
pfas-class PFAS structural alert (1 = True, 0 = False) 0
pppb Pig plasma protein binding (% unbound) 83.620 % High 1
rh-clint Rat hepatocyte intrinsic clearance 1.799 uL/min/10^6 cells High 1
rh-fuinc Rat hepatocyte fraction unbound in incubation 92.870 % High 1
rppb Rat plasma protein binding (% unbound) 94.620 % High 1
solubility-dd Solubility at pH 7.4 in DMSO 920.450 uM High 1

Approvals:

DateAgencyCompanyOrphan
Sept. 12, 2012 FDA MCPRF

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
FDA MoA N0000000205 Radiopharmaceutical Activity
FDA EPC N0000177914 Radioactive Diagnostic Agent
CHEBI has role CHEBI:35207 radioactive tracer

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
High affinity choline transporter 1 Transporter Ki 6.17 CHEMBL

External reference:

IDSource
CHEBI:72322 CHEBI
CHEMBL2095207 ChEMBL_ID
DB09277 DRUGBANK_ID
DB09563 DRUGBANK_ID
M4AS4XGD4Q UNII
1425419 RXNORM
725525002 SNOMEDCT_US
C2698585 UMLSCUI
449688 PUBCHEM_CID

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Choline C 11 HUMAN PRESCRIPTION DRUG LABEL 1 52670-556 INJECTION 33.10 mCi INTRAVENOUS NDA 25 sections
Choline C 11 HUMAN PRESCRIPTION DRUG LABEL 1 60215-111 INJECTION 100 mCi INTRAVENOUS ANDA 16 sections
MIC B12 HUMAN PRESCRIPTION DRUG LABEL 4 70104-806 INJECTION 1 mg INTRAMUSCULAR unapproved drug other 1 sections